Analysts/Institutional Investor Meet/Con. Call Updates

16th August 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Mumbai 400001 Bandra (E) Mumbai 400051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub: Intimation of Schedule of investors meet Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the Listing Regulations, this is to inform you that the officials of the company will be participating in the following investor meeting: Date of Time Investor / Meeting Type of Nature of Location meeting name meeting Meeting Wednesday, 9:00 AM to Investors meeting In-person Group Mumbai, 19th August 5:00 PM organised by meeting Maharashtra 2026 to Nuvama Wealth Friday, 21st Management August Limited and ICICI 2026 Securities Limited The schedule of the above-mentioned meeting is subject to change, and the change may occur due to exigencies on the part of Investor / Company. No Unpublished Price Sensitive Information (UPSI) pertaining to the Company is intended to be discussed during the interactions. Kindly take the same on record. Thanking you, Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer